GC Cell to Participate in BioUSA... "Korea's First Specialized Partnering Booth Operation"

GC Cell announced on the 20th that it will participate for the first time in the global pharmaceutical and bio conference, '2024 BIO International Convention (BIO USA),' held in San Diego, California, USA, from the 3rd to the 6th of next month (local time), and will engage in global partnering activities.

[Photo by GC Cell]

At this BIO USA, GC Cell plans to set up and operate a dedicated partnering booth in the business forum area, which is a partnering space. According to the Biotechnology Innovation Organization (BIO), the organizer of the event, this is the first time a Korean pharmaceutical and bio company will operate a dedicated partnering booth. Unlike general exhibition booths that introduce services to customers, the dedicated partnering booth is a separate space designed to focus on in-depth discussions by providing an independent booth exclusively for partnering.

On the second day of the event, the 4th, James Park, CEO of GC Cell, is scheduled to reveal this year’s and future blueprints through a corporate presentation session and engage in communication with industry leaders.

This partnering activity aims to promote the technology export of Immuncell-LC, an anti-cancer immunotherapy that attracted significant attention from multinational pharmaceutical companies at the JP Morgan Healthcare Conference (JPMHC) held last January, as well as the CD5 chimeric antigen receptor (CAR)-natural killer (NK) therapy GCC2005 and the human epidermal growth factor receptor (HER)2 CAR-NK GCC20023 currently under development. It also aims to secure order opportunities based on its contract development and manufacturing organization (CDMO) capabilities for cell and gene therapies.

CEO James Park said, “GC Cell’s participation in this BIO USA is significant as it is the first Korean pharmaceutical and bio company to operate a dedicated business partnering booth. We have scheduled close interactions with various global pharmaceutical companies, and we will do our best to achieve meaningful results through in-depth partnering.”